The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis

INTRODUCTION: Remdesivir, an experimental antiviral drug has shown to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), both in vitro and in vivo. The present systematic review and meta-analysis were performed to quantify the safety and tolerability of remdesivir, based on safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Santenna, Chenchula, Vidyasagar, Kota, Amarneni, Krishna Chaitanya, Ghanta, Sai Nikhila, Sadasivam, Balakrishnan, Pathan, Saman, Padmavathi, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477695/
https://www.ncbi.nlm.nih.gov/pubmed/34594487
http://dx.doi.org/10.1177/20420986211042517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477695/
https://www.ncbi.nlm.nih.gov/pubmed/34594487
http://dx.doi.org/10.1177/20420986211042517

Ejemplares similares